Myocardial Flow Reserve Partially Recovered after Additional Intensive Anti-Hyperglycemic Therapy in Patients with Type 2 Diabetes

Myocardial Flow Reserve Partially Recovered after Additional Intensive Anti-Hyperglycemic Therapy in Patients with Type 2 Diabetes

Impaired myocardial perfusion, such as coronary microangiopathy, is one of the important pathophysiological characteristics of diabetes  and a clinically important unresolved clinical question. The importance of glycemic control in the development of atherosclerosis in patients with diabetes has been suggested. We previously reported that myocardial flow reserve (MFR) was related to glycemic control rather than to the mode of therapy in patients with type 2 diabetes (T2DM).